Novo Health & Hygiene Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -77.21%
(FY 2020)
- Profit -758.13%
(FY 2020)
- Ebitda -1186.09%
(FY 2020)
- Net Worth -25.93%
(FY 2020)
- Total Assets -27.88%
(FY 2020)
About Novo Health & Hygiene
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh, Nachimuthu Dhanasekaran, Palanisamy Karthikeyan, and Four other members serve as directors at the Company.
- CIN/LLPIN
U52190TN2014PTC096328
- Company No.
096328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novo Health & Hygiene?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh  | Director | 24-Feb-2016 | Current |
| Nachimuthu Dhanasekaran | Director | 16-Jun-2016 | Current |
| Palanisamy Karthikeyan | Director | 13-Feb-2017 | Current |
| Mani Neelamani | Director | 25-Oct-2017 | Current |
| Jayamurugan Gunamaalini | Director | 25-Oct-2017 | Current |
| Muthusamy Jayamurugan | Director | 25-Oct-2017 | Current |
Financial Performance of Novo Health & Hygiene.
Novo Health & Hygiene Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 77.21% decrease. The company also saw a substantial fall in profitability, with a 758.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novo Health & Hygiene?
In 2019, Novo Health & Hygiene had a promoter holding of 16.67% and a public holding of 83.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unifrin Multinational Private LimitedActive 6 years 15 daysMani Neelamani and Muthusamy Jayamurugan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novo Health & Hygiene?
Novo Health & Hygiene has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novo Health & Hygiene, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Health & Hygiene's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
